Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. (Q37226286)
Jump to navigation
Jump to search
scientific article published on August 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. |
scientific article published on August 2008 |
Statements
Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results (English)
N Planas
S Prades
M Rubio
O Pujol